Literature DB >> 6290728

Relationship between the content of estrogen and progesterone receptors and the pathological characteristics in human breast cancer.

R Nishimura, A Misumi, M Kimura, T Tokunaga, M Akagi.   

Abstract

Assays of estrogen receptors (ER) and progesterone receptors (PgR) were performed by using the dextran-coated charcoal (DCC) method in 124 cases of invasive breast cancer. The results were correlated with clinical and pathological characteristics. There was no correlation between steroid hormone receptor contents and menopausal status, size of tumor, axillary lymph node status, or histological type. The presences of ER and PgR were significantly correlated with histological grade and its mitotic component. 78.3% of well-differentiated (Grade I) tumors were ER positive. Of this number, 61.1% were also PgR positive. In contrast, 69.0% of poorly differentiated (Grade III) tumors were ER and PgR negative. Tumors with a prominent lymphoid infiltration demonstrated a low frequency of positive ER and PgR. There was a significant inverse correlation between the degree of lymphoid infiltration and histological grade. These results suggest that the ER and PgR status of tumors may indicate a malignancy, and prognostic information can thus be obtained independently of other known factors such as size of the tumor and axillary lymph node status.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6290728     DOI: 10.1007/bf02469586

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  23 in total

1.  Predicting response to endocrine therapy in human breast cancer: a hypothesis.

Authors:  K B Horwitz; W L McGuire
Journal:  Science       Date:  1975-08-29       Impact factor: 47.728

2.  Progesterone "receptor" in rabbit uterus. I. Characterization and estradiol-17beta augmentation.

Authors:  B R Rao; W G Wiest; W M Allen
Journal:  Endocrinology       Date:  1973-04       Impact factor: 4.736

3.  Pathological review of breast lesions analyzed for estrogen receptor protein.

Authors:  P P Rosen; C J Menendez-Botet; J S Nisselbaum; J A Urban; V Miké; A Fracchia; M K Schwartz
Journal:  Cancer Res       Date:  1975-11       Impact factor: 12.701

4.  The pathology of invasive breast cancer. A syllabus derived from findings of the National Surgical Adjuvant Breast Project (protocol no. 4).

Authors:  E R Fisher; R M Gregorio; B Fisher; C Redmond; F Vellios; S C Sommers
Journal:  Cancer       Date:  1975-07       Impact factor: 6.860

5.  Low incidence of estrogen receptor in breast carcinomas with rapid rates of cellular replication.

Authors:  J S Meyer; B R Rao; S C Stevens; W L White
Journal:  Cancer       Date:  1977-11       Impact factor: 6.860

6.  Prognostic value of estrogen receptor determinations in patients with breast cancer.

Authors:  M A Rich; P Furmanski; S C Brooks
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

7.  Estrogen receptor in breast cancer of the Japanese.

Authors:  Y Nomura
Journal:  Gan       Date:  1976-10

8.  Estrogen receptor and endocrine responsiveness in Japanese versus American breast cancer patients.

Authors:  Y Nomura; S Kobayashi; O Takatani; H Sugano; K Matsumoto; W L McGuire
Journal:  Cancer Res       Date:  1977-01       Impact factor: 12.701

9.  The surgical implications of estrophile protein estimations in carcinoma of the breast.

Authors:  A J Walt; A Singhakowinta; S C Brooks; A Cortez
Journal:  Surgery       Date:  1976-10       Impact factor: 3.982

10.  Relationship between oestrogen-receptor content and histological grade in human primary breast tumours.

Authors:  P V Maynard; C J Davies; R W Blamey; C W Elston; J Johnson; K Griffiths
Journal:  Br J Cancer       Date:  1978-12       Impact factor: 7.640

View more
  4 in total

1.  Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in human breast cancer.

Authors:  W Remmele; U Hildebrand; H A Hienz; P J Klein; M Vierbuchen; L J Behnken; B Heicke; E Scheidt
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1986

2.  Tamoxifen binding sites in human mammary cancers.

Authors:  N Fujino; M Kimura; K Sakamoto; N Shigaki; J Yamashita; M Akagi
Journal:  Jpn J Surg       Date:  1986-09

3.  Significance of the Tritiated Thymidine Labeling Index in breast cancers.

Authors:  K Araki; M Kimura; K Sakamoto; R Nishimura; M Akagi
Journal:  Jpn J Surg       Date:  1985-03

4.  Reduction of estrogen and prolactin receptors in 7,12-dimethylbenz(a)anthracene-induced rat mammary tumor by high doses of estrogen.

Authors:  N Shigaki; M Kimura; S Takano; N Fujino; M Akagi
Journal:  Jpn J Surg       Date:  1987-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.